Published on in CHOP News
CHOP researchers discovered a new condition, which they named PU.MA, and treated a patient with a bone marrow donation from the patient’s older brother.
Published on in CHOP News
Using deep immune profiling, CHOP researchers have found children with MIS-C are extremely immune activated, more like adults with severe COVID-19.
Published on in CHOP News
CHOP researchers found the elevated biomarker in all children who tested positive for SARS-CoV-2, whether they were symptomatic for COVID-19 or not.
Published on in CHOP News
CHOP researchers show convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Published on in CHOP News
Breaking Through with Madeline Bell’s “Where We Are Now” series highlights CHOP doctors and researchers who are working to bring an end to the COVID-19 pandemic.
Published on in Children's Doctor
Latest news including COVID-19 models, care and research.
Published on in CHOP News
CHOP researchers have identified lab profiles that differentiate MIS-C from severe COVID-19 in children.
Published on in Children's View
Understanding the biology of both COVID-19 illness and MIS-C will enable scientists to develop much more specific diagnostic tests and help clinicians identify children who are at risk.
Published on in CHOP News
As COVID-19 continues to spread worldwide, teams at Children’s Hospital of Philadelphia are using a collaborative approach to identify and test potential treatments.
Published on in Children's View, Breakthrough Report
Two extraordinary programs are solving medical mysteries and envisioning the breakthroughs of tomorrow.